Chinese coronavirus vaccine could be tested, manufactured in Canada


TORONTO: China’s CanSino Biologics, the company behind one of the few coronavirus vaccine candidates already in clinical trials, is collaborating with Canada’s National Research Council to “pave the way” for future trials in Canada, the research council said on Tuesday. The NRC said it would scale up a production process for CanSino’s vaccine candidate at a government facility in Montreal, and that CanSino was preparing a clinical trial application for Health Canada, the country’s drug regulator.